Anthropic Pushes Into Drug Development With Claude Science
Anthropic details Claude-assisted cancer research and its own rare-disease programs, expanding its biotech role alongside pharmaceutical partnerships.
AGI, or artificial general intelligence, describes a hypothetical AI system with broad cognitive abilities rather than expertise limited to one task. Such a system could transfer knowledge between unfamiliar problems, learn new skills with limited instruction, reason across domains, and adapt its approach as circumstances change. Today’s language, vision, and robotics models can be highly capable, but they remain uneven and dependent on training patterns, tools, and human-defined objectives. Researchers debate how AGI should be measured, whether human-level performance is the right benchmark, and what technical safeguards would be needed before a generally capable system could be deployed responsibly.
Anthropic details Claude-assisted cancer research and its own rare-disease programs, expanding its biotech role alongside pharmaceutical partnerships.
OpenAI and Anthropic claim AI-generated proofs refute the Exponential Time Hypothesis. Lean checks support the claims, while expert scrutiny remains essential.
Researchers prompted Claude Fable 5.1 to hide messages in images. OpenAI’s Astra decoded 88% of them, without seeing the SVG source or an agreed cipher.
OpenAI resumed frontier AI training on October 1 after an 11-day pause, strengthening safeguards and blocking live internet access after a containment failure.
Block’s Dessa learns from speech alone and talks while listening. Its expressive demos preview a new approach to voice AI, with access limited to researchers.
Kevin Weil’s Warp Sciences will build U.S. chemistry labs for drug developers, combining expert scientists with AI and progressively automated workflows.
Carbon-X lets researchers ask questions about DNA and approaches GPT-6.1 Sol on the team’s benchmarks, but it is not validated for medical decisions.
Mass General Brigham’s FAHR-Face analyzes facial photographs to estimate aging and cancer survival risk, but clinical benefit still needs testing.
Google Deep Review offers two free document checks a week, using AI agents to flag errors and weak arguments. Its benchmark results come with important limits.
H2O.ai’s 2026 AI 100 recognizes model builders, researchers and business leaders, with honorees spanning nearly 90 organizations worldwide.